A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
Launched by UNIVERSITY OF WASHINGTON · May 7, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new approach to help older patients who have survived serious illnesses in the intensive care unit (ICU). Many of these patients, especially those aged 60 and older, can experience serious cognitive issues, similar to mild Alzheimer's disease, after they leave the hospital. The study aims to see if combining strategies to improve sleep and provide cognitive training can help these patients recover better and reduce the risk of cognitive decline and Alzheimer's disease. The researchers believe that timing these interventions to align with the body’s natural rhythms, known as circadian rhythms, may enhance their effectiveness.
To be eligible for this trial, participants must be at least 60 years old, have spent more than 24 hours in the ICU, and be currently hospitalized at the University of Washington Medical Center. They also need to have been independent in daily activities before their hospitalization. However, individuals with a history of Alzheimer's disease, dementia, certain mental health conditions, or severe impairments might not be able to participate. If enrolled, participants can expect to take part in activities aimed at improving their sleep and cognitive function, which could help them recover more fully after their time in the ICU.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age greater than or equal to 60 years old
- • Current hospitalization at University of Washington Medical Center or Harborview Medical Center
- • Intensive care unit (ICU) length of stay greater than 24 hours
- • Recovery from critical care status to acute care status, and/or discharge out of ICU
- • Fluent in English or Spanish
- • Functional independence on activities of daily living prior to hospitalization (Katz Index = 6)
- Exclusion Criteria:
- • Documented history or suspicion of Alzheimer's disease or dementia, or current prescription of anti-dementia medication
- • Documented history of bipolar disorder or schizophrenia
- • Documented acute stroke or traumatic brain injury
- • Severe vision impairment
- • Severe hearing impairment
- • Severe paralysis or dominant arm paresis
- • Transfer from skilled nursing care facility or inpatient rehabilitation facility
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Maya N Elias, PhD, MA, RN
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported